Friday, July 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “ras”

843 pharma patents match "ras" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 843
Index total 30,257
Page 8 / 36

Quick answer

This filtered view shows 843 pharmaceutical patents matching "ras" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

843 results for “ras” · 30,257 patents in full index Clear search

  1. US 11306132

    HLA class II-restricted T cell receptors against mutated RAS

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 19, 2022 · Expires Apr 14, 2042

    granted

  2. US 11291663

    Methods of treating cancer with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted Apr 5, 2022 · Expires Mar 31, 2042

    granted

  3. US 11267812

    KRAS G12C inhibitors

    Mirati Therapeutics, Inc. · Granted Mar 8, 2022 · Expires Mar 3, 2042

    granted

  4. US 11261461

    Methods and compositions for selective generation of dopaminergic precursors

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Mar 1, 2022 · Expires Feb 24, 2042

    granted

  5. US 11261230

    Synthetic somatostatin receptor ligands

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Mar 1, 2022 · Expires Feb 24, 2042

    granted

  6. US 11261237

    Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating neovascular diseases, inflammatory diseases, cancer, and for cytoprotection

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Mar 1, 2022 · Expires Feb 24, 2042

    granted

  7. US 11254739

    Anti-human migration stimulating factor (MSF) and uses thereof

    HUMANITAS MIRASOLE S.P.A. · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  8. US 11254683

    Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

    Prelude Therapeutics, Incorporated · Granted Feb 22, 2022 · Expires Feb 17, 2042

    granted

  9. US 11230565

    Synthesis of backbone modified morpholino oligonucleotides and chimeras using phosphoramidite chemistry

    The Regents of the University of Colorado · Granted Jan 25, 2022 · Expires Jan 20, 2042

    granted

  10. US 11219636

    Compositions and methods for treating cancer

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Jan 11, 2022 · Expires Jan 6, 2042

    granted

  11. US 11220524

    Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

    Prelude Therapeutics, Incorporated · Granted Jan 11, 2022 · Expires Jan 6, 2042

    granted

  12. US 11214574

    Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)

    Prelude Therapeutics, Incorporated · Granted Jan 4, 2022 · Expires Dec 30, 2041

    granted

  13. US 11207314

    Methods of treating cancer patients with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  14. US 11208411

    Compositions and methods for treating parasitic diseases

    The Regents of the University of California · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  15. US 11208456

    Anti-KRAS-G12D T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  16. US 11208416

    Selective inhibitors of protein arginine methytransterase 5 (PRMT5)

    Prelude Therapeutics, Incorporated · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  17. US 11207394

    Anti-mutated KRAS T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  18. US 11207429

    Method and compositions for orally administered contrast agents for MR imaging

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  19. US 11207283

    Inactivators of toxoplasma gondii ornithine aminotransferase for treating toxoplasmosis and malaria

    Northwestern University · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted

  20. US 11203596

    Analogs of 3-amino-4-(propan-2-ylidene)cyclopentane-1-carboxylic acid and uses thereof for treating diseases and disorders associated with ornithine aminotransferase activity

    Northwestern University · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted

  21. US 11197907

    Antimicrobial compounds from the genus Delftia

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

  22. US 11197847

    Isoxazoline parasiticide formulations and methods for treating blepharitis

    Tarsus Pharmaceuticals, Inc. · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

  23. US 11185600

    Contrast agent and its use for imaging

    Stichting Radboud universitair medisch centrum · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted

  24. US 11180499

    Phosphodiesterase inhibitors

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Nov 23, 2021 · Expires Nov 18, 2041

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.